Beijing Science Sun Pharmaceutical Co.,Ltd.’s Net Profit Rose 88.2% in First Three Quarters of 2022

Beijing Science Sun Pharmaceutical Co.,Ltd. (北京赛升药业股份有限公司) (300485.SZ) reported a net profit of 250.2 million yuan in the first three quarters of 2022, up 88.2% year-on-year.

Meanwhile, the company posted 599.2 million yuan in revenue, down 26% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 114.1 million yuan in total liabilities, with a liability-to-asset ratio of 3.2%.